203 reports of this reaction
1.0% of all OXYMORPHONE HYDROCHLORIDE reports
#13 most reported adverse reaction
ILL DEFINED DISORDER is the #13 most commonly reported adverse reaction for OXYMORPHONE HYDROCHLORIDE, manufactured by Amneal Pharmaceuticals LLC. There are 203 FDA adverse event reports linking OXYMORPHONE HYDROCHLORIDE to ILL DEFINED DISORDER. This represents approximately 1.0% of all 20,768 adverse event reports for this drug.
Patients taking OXYMORPHONE HYDROCHLORIDE who experience ill defined disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ILL DEFINED DISORDER is a less commonly reported adverse event for OXYMORPHONE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to ill defined disorder, the following adverse reactions have been reported for OXYMORPHONE HYDROCHLORIDE:
The following drugs have also been linked to ill defined disorder in FDA adverse event reports:
ILL DEFINED DISORDER has been reported as an adverse event in 203 FDA reports for OXYMORPHONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ILL DEFINED DISORDER accounts for approximately 1.0% of all adverse event reports for OXYMORPHONE HYDROCHLORIDE, making it a notable side effect.
If you experience ill defined disorder while taking OXYMORPHONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.